drug
EL-22
Phase 1updated 3mo agoby Northstrive Biosciences Inc
Phase 1community read0 votes
indications
indications
ObesityDuchenne Muscular Dystrophy
all catalysts(0)
nothing on the calendar yet
Trials studying EL-22
- phase2PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- phase1A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
- phase2Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that